President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Lecanemab binds with high affinity to soluble amyloid-beta protofibrils. It won full FDA approval in July 2023 based on trial ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

RFK Jr., Trump, and Republicans want AI to fill the gaps as they move to throw millions off Medicaid, gut funding for ...

President Donald Trump has now been in office for more than 100 days, and investors certainly have a much more clear picture ...

After significant fanfare and anticipation, President Trump issued his “Delivering Most-Favored Nation Prescription Drug Pricing to American ...

For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...

To be clear, that concern was well-founded: High drug prices are one reason the U.S. has become a global leader in medical innovation. Some of the most important advancements in the field — from ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...